NEW YORK (Reuters Health) ? Laparoscopic antireflux surgery (LARS) and the proton pump inhibitor (PPI) esomeprazole are similarly effective, safe, and well tolerated strategies for the management of…
NEW YORK (Reuters Health) – The risk of developing ulcerative colitis and Crohn’s disease is associated with iron levels in drinking water, according to a study in Norway.…
NEW YORK (Reuters Health) – An infusion of dexamethasone-loaded autologous erythrocytes appears to be an effective treatment for mild-to-moderate ulcerative colitis that is refractory to mesalamine, new research…
NEW YORK (Reuters Health) – Detection of JC virus, an important cause of progressive multifocal leukoencephalopathy (PML) in immunosuppressed patients, is not a good predictor of PML risk…
NEW YORK (Reuters Health) – On screening colonoscopy, polyps greater than 9 mm in diameter are more likely to be detected in black individuals than in their white…
NEW YORK (Reuters Health) – The results of a randomized trial suggest that statins may be a useful treatment for Raynaud’s phenomenon and digital ulcers that can accompany…
NEW YORK (Reuters Health) – If an initial screening colonoscopy indicates no colorectal neoplasia, the odds that a malignancy will develop in the next 5 years is “extremely…
NEW YORK (Reuters Health) – Gastric acid suppression by proton pump inhibitors (PPIs) is associated with an increased risk of Clostridium difficile-related diarrhea in hospitalized patients, results of…
NEW YORK (Reuters Health) – New research indicates that many older patients who survive colorectal cancer do not receive guideline-recommended follow-up with office visits, carcinoembryonic antigen (CEA) testing,…
NEW YORK (Reuters Health) – Men who gain weight during adulthood – even those who are not considered to be overweight according to their body mass index –…